MARKET

ATHXQ

ATHXQ

Athersys Inc
OTCPK
0.013
+0.002
+19.05%
Closed 11:55 02/26 EST
OPEN
0.011
PREV CLOSE
0.011
HIGH
0.013
LOW
0.011
VOLUME
104.33K
TURNOVER
1.20K
52 WEEK HIGH
1.990
52 WEEK LOW
0.0045
MARKET CAP
771.48K
P/E (TTM)
-0.0062
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ATHXQ last week (0219-0223)?
Weekly Report · 11h ago
Weekly Report: what happened at ATHXQ last week (0212-0216)?
Weekly Report · 02/19 10:43
Weekly Report: what happened at ATHXQ last week (0205-0209)?
Weekly Report · 02/12 10:36
Weekly Report: what happened at ATHXQ last week (0129-0202)?
Weekly Report · 02/05 10:42
Weekly Report: what happened at ATHXQ last week (0122-0126)?
Weekly Report · 01/29 10:34
Weekly Report: what happened at ATHXQ last week (0115-0119)?
Weekly Report · 01/22 10:37
Weekly Report: what happened at ATHXQ last week (0108-0112)?
Weekly Report · 01/15 10:35
Weekly Report: what happened at ATHX last week (0101-0105)?
Weekly Report · 01/08 10:37
More
About ATHXQ
Athersys, Inc. is a biotechnology company focused primarily on the field of regenerative medicine. The Company is engaged in the discovery and development of therapeutic product candidates to address unmet medical needs in multiple disease areas. Its MultiStem (invimestrocel) cell therapy, which is an allogeneic stem cell product candidate, is its lead platform product and is in late-stage clinical development. MultiStem cell therapy includes treatment of critical care indications, neurological conditions, inflammatory and immune disorders, certain pulmonary conditions, cardiovascular disease, and other conditions. MultiStem cell therapy is manufactured from human stem cells obtained from adult bone marrow and these cells are alternatively obtained from other tissue sources. It is conducting a Phase III clinical trial of MultiStem cell therapy for the treatment of ischemic stroke, referred to as MultiStem Administration for Stroke Treatment and Enhanced Recovery Study-2 (MASTERS-2).

Webull offers Athersys Inc stock information, including OTCPK: ATHXQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATHXQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATHXQ stock methods without spending real money on the virtual paper trading platform.